Extracellular vesicles derived from mesenchymal stem cells as a potential therapeutic agent in acute kidney injury (AKI) in felines: review and perspectives.

Stem Cell Res Ther · 2021 · PMC8444608 · PMID 34526105

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

barely significantno p-value reported

It can be said that adverse effects are barely significant after MSCs administrating encourages to further develop therapy using MSCs or derived from the EVs.

also in 875 other papers

may be significantno p-value reported

This for sure indicates that MSC-EXOs could inhibit the NF-κB pathway, which may be significant during the inflammation development in IRI [ 44 , 57 , 58 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.